News & Events

31

Jan2022

Updates to the Ontario Guidelines for Drug Submission and Evaluation

/ Ontario, What's New
The Ontario Ministry of Health has recently updated the Ontario Guidelines for Drug Submission and Evaluation (Guidelines). In an effort to reduce complexity and simplify their policy document, specific guidelines aiming to address individual product types are now available on the Ontario Ministry of Health website.... Read More

14

Jan2022

REGISTER NOW for PDCI’s Webinar: Impact and Implications of the Delayed Regulations and PMPRB Guidelines

/ Upcoming Events, What's New
Join us on January 25, 2022 for insights and guidance on the potential impact of delayed PMPRB Pricing Regulations and Guidelines. Health Canada’s announcement on December 23, 2021 delayed the coming into force date for the Patented Medicines Regulations by a further ... Read More

31

Dec2021

PDCI Year in Review

/ What's New
As 2021 comes to an end, PDCI is reflecting on the year we've had in Canadian market access. PDCI's 2021 Year in Review highlights important milestones that occurred in 2021 and looks forward at Trends to Watch in 2022. Click here for the PDF version... Read More

28

Dec2021

Further Delay to the PMPRB Guidelines and amended Regulations

/ What's New
Health Canada announced on December 23, 2021 that the coming into force of the Patented Medicines Regulations has been delayed for another 6 months to July 1, 2022. As a result, implementation of the New PMPRB Guidelines (which in part rely on the amended Regulations) are also delayed until July ... Read More

17

Dec2021

PDCI’s 2021 Census of Insurers

/ Publications, What's New
PDCI is pleased to announce the release of the 2021 update to the Census of Insurers. The Census of Insurers is available exclusively through the PDCI Market Access Toolkit. PDCI’s Census of Insurers estimates the market share and private covered lives by insurer across Canada. Private payer and access managers ... Read More

17

Dec2021

New PDCI Market Access INSIGHTS Volume 2, Issue 1

/ Publications, What's New
PDCI releases new issue of PDCI Market Access INSIGHTS, featuring research and opinion on the evolving state of private health insurance in Canada. VOLUME 2, ISSUE 1... Read More

17

Dec2021

PMPRB Proposed Amendments to the July 1, 2021 Guidelines

/ PMPRB, What's New
On October 28th, 2021, PMPRB provided their first update to the Notice & Comment that was issued on July 15, 2021. The primary takeaway is PMPRB will be providing patentees two reporting periods for compliance, a change from PMPRB's earlier position expecting one reporting period for ... Read More

17

Dec2021

Consultation Notice: Proposed Framework for a Potential Pan-Canadian Formulary

/ Canada, National Pharmacare, News, What's New
Consultation on the Proposed Framework for a Potential Pan-Canadian Formulary will be open for feedback from January 11 - February 25, 2022.  A discussion paper summarizing the Advisory Panel’s interim recommendations and proposed process will be posted on the CADTH website and CADTH will host an information session on January 18, 2022 at 1 p.m. (ET).  ... Read More

17

Dec2021

CADTH Pharmaceutical Reviews Update- Issue 27

/ CADTH, News, What's New
On December 16, 2021, CADTH provided an update regarding CADTH’s drug review programs. A. Expanded Provisional Funding Algorithm Process CADTH has expanded the provisional funding algorithm process to include a new rapid algorithm process. This rapid algorithm process will be ... Read More

07

Dec2021

WHITEPAPER: Uncovering the Hidden Costs of Take-Home Cancer Drugs

/ PDCI, Publications, What's New
In cancer care, patients often face increased anxiety and uncertainty about their future care pathway. This is paired with an immediate need for therapy to treat potentially aggressive disease. Coverage eligibility for THCD varies significantly across Canadian provinces, creating interprovincial differences. Gaps in coverage of THCDs across provinces lead to inequitable ... Read More